← FDA Drug Approvals (Drugs@FDA)

LAMOTRIGINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2013-10-17

Drug application

FDA Application #

ANDA200672

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMOTRIGINE

Generic name

LAMOTRIGINE

Active ingredients

LAMOTRIGINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS ELIZABETH

Manufacturer

Actavis Pharma, Inc.

First approval

2013-10-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown